Back to search
FDAFDA · Food and drugs·Recall number D-0009-2019

robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA 19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN 47274; NDC 52244-449-10.

Published October 10, 2018 · Recall initiated: September 17, 2018

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states "Two to four tablets four times daily." rather than the correct dosage of "Two tablets three times daily."

What to do

Voluntary: Firm initiated · Letter

Recall details

Manufacturer
Endo Pharmaceuticals, Inc.
Distributor
Nationwide in the USA.
Lot
Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21
Risk classification
Class I
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card